In RA, type 4 PAD (PAD4, encoded by PADI4 on chromosome 1p) is preferentially expressed in hematopoietic cells, contributes to the generation of ACPA-specific substrates, and is also a target of disease-specific autoantibodies [4]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.